Brand Name: OMEGESIC
Generic Name: Omeprazole USP
Available Strengths:
Omeprazole USP 20mg/40mg (as enteric coated pellets)
Omeprazole Delayed-Release (DR) Capsules USP are proton pump inhibitors (PPIs) formulated to manage acid-related gastrointestinal conditions such as gastroesophageal reflux disease (GERD), duodenal and gastric ulcers, Zollinger-Ellison syndrome, and erosive esophagitis. The delayed-release formulation ensures the active ingredient passes through the stomach and dissolves in the intestine, improving bioavailability and therapeutic effect. Omeprazole works by selectively inhibiting gastric proton pumps, reducing acid secretion, and promoting healing of the gastric and esophageal mucosa. Manufactured under stringent quality standards, these capsules provide fast, long-lasting relief from heartburn, acid reflux, and other gastric discomforts when taken as directed by a healthcare professional.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com